Bristol-Myers Squibb Company
NYSE: BMY
$58.50
+$0.09 (+0.2%)
Closing Price on November 14, 2024
BMY Articles
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Published:
Some sectors showed mixed results in the short selling, but the Big Pharma and medical instruments and related companies saw an increased activity in short selling in May versus April. Below is the...
Published: